Researchers discover a critical cellular “off” switch for the inflammatory immune response that causes asthma attacks
Working with human immune cells in the laboratory, Johns Hopkins researchers report they have identified a critical cellular “off” switch for the inflammatory immune response that contributes to lung-constricting asthma attacks. The switch, they say, is composed of regulatory proteins that control an immune signaling pathway in cells.
“Asthma patients are constantly firing through this pathway because those proteins are stuck in the ‘on’ position, without proper control by other proteins that shut down this reaction,” says Nicola Heller, Ph.D., assistant professor of anesthesiology and critical care medicine at the Johns Hopkins University School of Medicine.
Asthma has been correlated with an overabundance of one type of immune cell called M2 macrophages in the lungs. In a nonasthmatic person, the M2 macrophages activate to clean up inhaled allergens and foreign particles, and then deactivate when the irritant is broken down.
However, in people with asthma, the M2 cells and the chemical signals they emit linger and call in other cells that cause inflammation that can trigger an asthma attack with the classic symptoms of difficulty breathing, wheezing and shortness of breath. Over time, the lung is changed by secretions from the M2 cells, which cause the lung tissue to remodel itself, contributing to irreversible obstruction and poor lung function. “If you prevent these cells from becoming the M2 type, you can potentially stop the continued inflammation and long-term structural changes,” says Heller.
The new research, reported Nov. 25 in the Journal of Biological Chemistry, investigated the role of two proteins, GRB10 and p70S6K, in the control of the signaling pathway that activates M2 cells.
In their previous work, also published in the Journal of Biological Chemistry Sept. 23, Heller’s group found that the inflammatory pathway involving the two proteins begins with interleukin 4 (IL-4), an immune system chemical that passes through a protein named IRS-2 before activating the M2 cells. They found that other proteins that stop the action of IRS-2 were not present in human M2 cells from people with allergies compared to healthy people. This made IRS-2 more active and increased the formation of M2 cells in people with allergies.
In the new study, Heller’s lab delved deeper into the IRS-2 pathway. By analyzing chemical changes of the IRS-2 protein in immortalized cultures of human white blood cells, it determined that IRS-2 appeared in two different forms — “on,” which allows the signal to pass through, and “off,” which stops the signal from activating the cells into M2 macrophages. They began by observing which proteins became active in the presence of IL-4 in human white blood cells and add “stop” signals to IRS-2. The activity of two regulatory proteins, GRB10 and p70S6K, increased after IL-4 exposure compared to the same cells that were not exposed to IL-4.
In further test tube experiments, the researchers treated the immortalized white blood cells with both chemical and genetic blockers, called small interfering RNA (siRNA), designed to render either p70S6K or GRB10 nonfunctional. The researchers saw that decreased GRB10 and p70S6K activity resulted in more of the “on” form of IRS-2, meaning these proteins are responsible for turning off IRS-2 and thereby downstream M2 production.
“This confirmed for us that without properly functioning GRB10 and p70S6K, the cells could not turn off IRS-2 signaling and M2 production,” says Heller.
The research team, Heller says, has already begun experiments to further explore the implications of these results, which include looking at differences in this pathway between cells taken from allergic and healthy individuals, and testing the efficacy of an inhalable drug that mimics the function of GRB1 and p70S6K to shut off the development of M2 macrophages in the lungs of mice. “One of the advantages of working with lung macrophages is that they are one of the first cells that see anything that gets put in an inhaler,” says Heller. “So we hope to modulate their activity in this way.”
These findings also have implications for treatment of cancer and other disorders, such as obesity, in which M2 macrophage cells play a regulatory role in tumor growth and fat deposition.
Learn more: Turning off Asthma Attacks
[osd_subscribe categories=’asthma’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “ASTHMA”‘]
Receive an email update when we add a new ASTHMA article.
The Latest on: Asthma
[google_news title=”” keyword=”Asthma” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Asthma
- OHSU doctor says rainy weather can help those with asthmaon May 10, 2024 at 5:15 pm
With the uptick in temperatures, many allergy sufferers see an increase in symptoms. Those with asthma may have to take more precautions on a daily basis.
- The number of asthma deaths has risen by 30 per cent across Australiaon May 10, 2024 at 4:01 pm
The number of asthma deaths has risen by 30 per cent in a year across Australia. It's the biggest number of casualties caused by the respiratory illness in a decade.
- 7 Surprising Asthma Triggers to Know Abouton May 10, 2024 at 1:00 am
During an asthma attack, the airways responsible for bringing fresh oxygen into the body become inflamed. The muscles in the lungs and bronchial tree (or the windpipe and channels connecting it to the ...
- Chronic asthma could be caused by cell overcrowding in the airwayson May 9, 2024 at 4:59 pm
Despite a wealth of available treatments to control the symptoms of chronic asthma, the lung disease has no cure. The discovery of an unexpected cause of asthma could change that. A glitch in the ...
- Doctors Answer Common Questions About Pollen And Asthma.on May 9, 2024 at 2:28 pm
How does pollen trigger asthma symptoms and attacks?Expert opinion from Dr. Anuvitha KamathMBBS · 3 years of experience · IndiaIn asthmatic people, pollen exposure can lead to the triggering and ...
- Professional Faqs: How Does Low Temperature Affect The Risk Of Infections For People With Asthma And What Precautions Should They Take?on May 9, 2024 at 2:28 pm
Low temperature can increase the risk of infections in people with asthma. Low temperature causes broncho-constriction, leading to increased mucus production and difficulty in the expiration of ...
- Avoidance Diets Linked to Adult-Onset Asthma, Study Findson May 9, 2024 at 11:05 am
Asking patients about their diet is important when evaluating for adult-onset asthma, allergic disease, and aspirin-exacerbated respiratory disease (AERD).
- What Triggers Asthma?on May 9, 2024 at 5:00 am
Asthma is a chronic condition that causes inflammation and tightening of the airways which can cause symptoms like difficulty breathing, wheezing, and coughing. Asthma is a common condition and ...
- Study reveals role of iron in allergic asthma and points to potential new therapieson May 8, 2024 at 11:00 am
New USC research shows that iron serves as a gas pedal driving certain immune cells that cause inflammation in the lungs during an allergic asthma attack—and blocking or limiting iron may reduce the ...
via Bing News